Delving into the Latest Updates on Jiangsu Wuzhong Medicine Group Co., Ltd. with Synapse

Overview

Tags

Other Diseases

Endocrinology and Metabolic Disease

Congenital Disorders

Small molecule drug

Herbal medicine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Endocrinology and Metabolic Disease	2
Infectious Diseases	1
Nervous System Diseases	1
Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	2
Herbal medicine	1

Top 5 Target	Count

VDR(Vitamin D receptor)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

1

2

Approved

Other

2

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Colecalciferol ( VDR )	Vitamin D Deficiency More	Approved
Citicoline Sodium	Brain Injuries More	Approved
Cornus officinalis Terpene Tablets	Early-onset type II diabetes More	Phase 1
Nitroxoline ( METAP2 )	Bladder Cancer More	Pending
Recombinant human endostatin (Wuzhong Pharmaceutical) ( Protein kinases )	Non-Small Cell Lung Cancer More	Pending